Fredun Pharmaceuticals share price history
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Fredun Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016
Last close ₹1,453.50down ₹18.70 (1.27%)BSE ₹1,450.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,472.20.
29 Oct: open ₹1,476.00, high ₹1,483.90, low ₹1,441.10
52-week range of BSE trades to 29 Oct 2026
₹454.05Low, 12 Jan 2026₹1,666.35High, 8 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,456 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 31,50352.9% delivered
Fredun Pharmaceuticals share price by year, month and day
Closes to 29 Oct 2026; the last month as traded on NSE
Fredun Pharmaceuticals' share price is on record from 28 Mar 2016, when it closed at ₹4.17, to 29 Oct 2026. Its highest close was ₹1,552.30 on 9 Oct 2026 and its lowest ₹4.17 on 28 Mar 2016, adjusted for 1 split or bonus issue. Some closes are BSE's, on days NSE has none.
Close at year end, ₹
Adjusted close. A day's closing price restated for every split and bonus issue since, so prices years apart compare as one share held throughout: after a 1:1 bonus, earlier closes are halved. Adjusted close: how it is worked out| Year | Close at year end | Change | Highest close | Lowest close | Open | Traded high | Traded low | Volume |
|---|---|---|---|---|---|---|---|---|
| 2026so farBSE close | 1,453.50 | +176.3% | 1,552.30 | 466.10 | 523.33 | 1,665.00 | 454.05 | 1,08,37,140 |
| 2025BSE close | 526.10 | +114.1% | 648.40 | 215.03 | 245.75 | 666.33 | 211.67 | 88,54,299 |
| 2024BSE close | 245.75 | −15.1% | 334.83 | 224.00 | 292.33 | 351.33 | 216.67 | 65,08,680 |
| 2023BSE close | 289.58 | −22.4% | 393.93 | 255.65 | 379.92 | 416.33 | 246.67 | 34,41,279 |
| 2022BSE close | 373.40 | +32.5% | 461.62 | 233.15 | 267.83 | 476.00 | 225.00 | 21,26,871 |
| 2021BSE close | 281.92 | +95.2% | 304.13 | 125.22 | 133.67 | 319.00 | 115.53 | 40,24,251 |
| 2020BSE close | 144.42 | +92.3% | 146.20 | 35.47 | 76.67 | 149.67 | 34.33 | 38,43,438 |
| 2019BSE close | 75.10 | −33.2% | 158.73 | 66.45 | 110.53 | 166.67 | 61.00 | 15,18,384 |
| 2018BSE close | 112.37 | +223.2% | 159.97 | 36.50 | 36.50 | 165.00 | 36.50 | 9,04,680 |
| 2017BSE close | 34.77 | +125.5% | 34.77 | 16.18 | 16.18 | 34.77 | 16.18 | 36,084 |
| 2016BSE close | 15.42 | – | 15.42 | 4.17 | 4.17 | 15.42 | 4.17 | 6,060 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before; traded high and low are the year's range. 2016 is from its first session, 28 Mar 2016.
| Month | Close | Change | Open | High | Low | Volume |
|---|---|---|---|---|---|---|
| Oct 2026so far | 1,453.50 | +3.5% | 1,404.50 | 1,665.00 | 1,315.80 | 30,37,758 |
| Sep 2026 | 1,404.50 | −2.9% | 1,463.70 | 1,531.00 | 1,195.20 | 14,42,447 |
| Aug 2026BSE close | 1,446.90 | +46.6% | 997.00 | 1,599.90 | 990.10 | 9,56,933 |
| Jul 2026BSE close | 987.00 | +5.2% | 930.00 | 999.00 | 823.93 | 7,80,866 |
| Jun 2026BSE close | 938.10 | +12.8% | 830.00 | 941.67 | 733.32 | 9,20,601 |
| May 2026BSE close | 831.85 | +11.9% | 746.70 | 873.33 | 721.65 | 9,36,681 |
| Apr 2026BSE close | 743.63 | +33.4% | 555.73 | 759.62 | 555.73 | 5,90,709 |
| Mar 2026BSE close | 557.27 | +2.9% | 505.05 | 613.33 | 484.17 | 4,94,913 |
| Feb 2026BSE close | 541.48 | +5.6% | 523.27 | 648.00 | 502.67 | 7,44,480 |
| Jan 2026BSE close | 512.77 | −2.5% | 523.33 | 542.33 | 454.05 | 9,31,752 |
| Dec 2025BSE close | 526.10 | −17.9% | 659.98 | 666.33 | 500.77 | 6,18,105 |
| Nov 2025BSE close | 641.15 | +25.0% | 492.00 | 657.08 | 490.37 | 6,81,564 |
| Oct 2025BSE close | 513.05 | +17.1% | 448.67 | 595.00 | 427.00 | 8,03,871 |
| Sep 2025BSE close | 438.22 | +14.3% | 391.00 | 451.67 | 383.67 | 8,28,828 |
| Aug 2025BSE close | 383.42 | +14.2% | 339.93 | 443.00 | 324.00 | 14,08,596 |
| Jul 2025BSE close | 335.68 | +21.3% | 281.63 | 340.00 | 264.67 | 14,54,547 |
| Jun 2025BSE close | 276.82 | +7.6% | 263.28 | 283.23 | 230.00 | 11,04,192 |
| May 2025BSE close | 257.22 | +11.0% | 231.80 | 262.17 | 222.00 | 5,06,259 |
| Apr 2025BSE close | 231.80 | +4.0% | 230.33 | 263.33 | 211.68 | 2,57,316 |
| Mar 2025BSE close | 222.85 | −1.8% | 228.00 | 239.98 | 216.73 | 5,10,684 |
| Feb 2025BSE close | 226.83 | +2.8% | 221.70 | 262.98 | 213.35 | 3,60,111 |
| Jan 2025BSE close | 220.57 | −10.2% | 245.75 | 254.92 | 211.67 | 3,20,226 |
| Dec 2024BSE close | 245.75 | 0.0% | 245.73 | 270.00 | 233.67 | 4,17,957 |
| Nov 2024BSE close | 245.73 | +4.4% | 243.30 | 266.63 | 218.33 | 4,30,794 |
₹ per share, adjusted for splits and bonuses since. Change is on the close of the month before; high and low are the month's traded range. After months with no trade, the change is on the last month with one.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 29 Oct 2026 | 1,476.00 | 1,483.90 | 1,441.10 | 1,453.50 | 1,459.25 | 31,503 | 52.9% |
| 28 Oct 2026 | 1,471.00 | 1,481.00 | 1,438.00 | 1,472.20 | 1,465.85 | 43,696 | 49.4% |
| 27 Oct 2026 | 1,389.00 | 1,460.00 | 1,372.80 | 1,450.90 | 1,432.99 | 61,674 | 60.2% |
| 26 Oct 2026 | 1,368.40 | 1,381.50 | 1,345.80 | 1,365.50 | 1,363.02 | 23,889 | 34.9% |
| 23 Oct 2026 | 1,398.90 | 1,398.90 | 1,315.80 | 1,368.40 | 1,348.64 | 52,749 | 40.2% |
| 22 Oct 2026 | 1,353.20 | 1,400.00 | 1,353.20 | 1,391.00 | 1,380.71 | 38,003 | 47.7% |
| 21 Oct 2026 | 1,436.90 | 1,450.30 | 1,329.90 | 1,365.90 | 1,380.45 | 1,53,208 | 56.3% |
| 19 Oct 2026 | 1,461.30 | 1,482.00 | 1,406.00 | 1,438.40 | 1,443.00 | 93,163 | 51.7% |
| 16 Oct 2026 | 1,476.40 | 1,500.00 | 1,433.20 | 1,477.70 | 1,469.91 | 49,897 | 48.0% |
| 15 Oct 2026 | 1,538.30 | 1,538.30 | 1,419.00 | 1,462.10 | 1,455.37 | 1,26,807 | 46.8% |
| 14 Oct 2026 | 1,477.00 | 1,553.00 | 1,477.00 | 1,517.60 | 1,515.87 | 77,017 | 38.9% |
| 13 Oct 2026 | 1,520.00 | 1,521.10 | 1,468.10 | 1,476.50 | 1,485.82 | 1,55,669 | 45.7% |
| 12 Oct 2026 | 1,579.00 | 1,579.00 | 1,456.60 | 1,504.20 | 1,500.89 | 1,76,073 | 43.0% |
| 9 Oct 2026 | 1,560.80 | 1,638.20 | 1,517.90 | 1,552.30 | 1,580.65 | 4,50,916 | 15.8% |
| 8 Oct 2026 | 1,488.00 | 1,665.00 | 1,462.70 | 1,531.70 | 1,575.40 | 10,74,150 | 14.8% |
| 7 Oct 2026 | 1,418.30 | 1,547.30 | 1,403.90 | 1,473.90 | 1,479.30 | 2,35,127 | 46.0% |
| 6 Oct 2026 | 1,356.00 | 1,424.90 | 1,356.00 | 1,406.70 | 1,398.25 | 82,965 | 51.3% |
| 5 Oct 2026 | 1,358.00 | 1,398.00 | 1,322.10 | 1,363.20 | 1,349.77 | 72,372 | 45.1% |
| 1 Oct 2026 | 1,404.50 | 1,407.30 | 1,334.10 | 1,355.20 | 1,368.87 | 38,880 | 43.0% |
| 30 Sep 2026 | 1,403.00 | 1,447.40 | 1,398.90 | 1,404.50 | 1,418.55 | 35,676 | 49.4% |
| 29 Sep 2026 | 1,393.80 | 1,424.90 | 1,295.00 | 1,392.40 | 1,406.34 | 91,403 | 46.3% |
| 28 Sep 2026 | 1,356.30 | 1,399.00 | 1,342.00 | 1,387.00 | 1,375.90 | 44,054 | 44.9% |
Prices in ₹ per share as traded, not adjusted.
Splits, bonus issues and other changes
What the prices above are adjusted for, so they read as one share held throughout.Fredun Pharmaceuticals bonus and split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 16 Jul 2026 | Bonus | 0.3333 | Holders received 2 bonus shares for every 1 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.